Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel

doi:10.3389/fonc.2021.791121

HFCAS OpenIR

	Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel
	Wei, Hangping 1; Mao, Jie 2; Wu, Yandan 3; Zhou, Qinfei 4,5
	2021-12-16
发表期刊	FRONTIERS IN ONCOLOGY
ISSN	2234-943X
通讯作者	Zhou, Qinfei(applewhp1988@163.com)
摘要	BackgroundPrimary adrenal epithelioid angiosarcoma is an extremely rare cancer with a poor prognosis. Because of the rarity of this disease, treatment options have not been well-studied. Case presentationA 51-year-old man was admitted to Zhejiang Cancer Hospital, diagnosed with a recurrence of adrenal epithelioid angiosarcoma. He had undergone a surgical resection seven months earlier. Combination chemotherapy with liposomal doxorubicin and paclitaxel was administered. After two cycles of chemotherapy, his pain was relieved. Computed tomography (CT) suggested that the soft tissue tumour lesions in the surgical area had disappeared, mediastinal and mediastinal-hilar lymph nodes were significantly reduced or had disappeared, and the patient had achieved a partial response (PR). CT after six cycles of chemotherapy indicated that the patient had achieved a complete response (CR). ConclusionCombination chemotherapy with liposomal doxorubicin and paclitaxel may be a preferred therapy for recurrent or advanced adrenal epithelioid angiosarcoma.
关键词	epithelioid angiosarcoma adrenal gland liposomal doxorubicin paclitaxel combination chemotherapy
DOI	10.3389/fonc.2021.791121
关键词[WOS]	GLAND
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000738472000001
出版者	FRONTIERS MEDIA SA
引用统计	被引频次：3[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/127238
专题	中国科学院合肥物质科学研究院
通讯作者	Zhou, Qinfei
作者单位	1.Wenzhou Med Univ, Dongyang Hosp, Dept Med Oncol, Dongyang, Peoples R China 2.Wenzhou Med Univ, Dongyang Hosp, Dept Radiol, Dongyang, Peoples R China 3.Wenzhou Med Univ, Dongyang Hosp, Dept Gynaecol & Obstet, Dongyang, Peoples R China 4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Rare & Head & Neck Oncol, Hangzhou, Peoples R China 5.Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Wei, Hangping,Mao, Jie,Wu, Yandan,et al. Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel[J]. FRONTIERS IN ONCOLOGY,2021,11.
APA	Wei, Hangping,Mao, Jie,Wu, Yandan,&Zhou, Qinfei.(2021).Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel.FRONTIERS IN ONCOLOGY,11.
MLA	Wei, Hangping,et al."Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel".FRONTIERS IN ONCOLOGY 11(2021).